Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...
Prachi Patkee and other analysts at Swiss Re offer that comfort to insurers, employers and patients in a new report on the impact of the new anti-obesity drugs on the insurance sectors.
Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...